ArticleDigestive diseases and sciences2026
Evaluation of Polyp Detection Rates Following Changes in Colonoscopy Surveillance Intervals.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn 2020, the U.S. Multi-Society Task Force (USMSTF) extended the surveillance interval for patients with 1-2 small (< 10 mm) tubular adenomas from 5-10 years to 7-10 years following a high-quality baseline colonoscopy. Whether longer intervals affect polyp yield at repeat colonoscopy remains unclear.
methodsFrom 9,300 patients who underwent colonoscopy in 2015 within the MedStar Health system, we identified individuals with 1-2 small tubular adenomas who subsequently completed surveillance colonoscopy. Patients were identified using ICD-10 codes and manual chart review. Extracted variables included demographics, BMI, smoking status, NSAID use, race/ethnicity, family history of colorectal cancer (CRC), Boston Bowel Preparation Score, withdrawal time, pathology results, and surveillance interval. Patients were stratified into two groups: < 7 years vs ≥ 7 years between baseline and repeat colonoscopy. Primary outcomes were the detection of any polyp and neoplastic polyps (precancerous, advanced adenoma, SSL etc.). Group differences were evaluated using Wilcoxon rank-sum and Fisher's exact tests.
resultsA total of 399 patients met the inclusion criteria (326 < 7 years; 73 ≥ 7 years). Median follow-up time was 4.4 years vs 8.0 years, respectively (p < 0.001). Baseline characteristics-including age, gender, race/ethnicity, BMI, smoking status, NSAID use, and family history of CRC-were similar between groups, with no statistically significant differences (all p > 0.05). Procedure quality indicators such as Boston Bowel Preparation Score and withdrawal time, were also comparable. At repeat colonoscopy, patients with ≥ 7-year intervals had numerically higher rates of any polyp detection (67% vs 57%; p = 0.15) and neoplastic polyps (55% vs 48%; p = 0.30), though these differences were not statistically significant.
conclusionsAmong patients with 1-2 small, low-risk tubular adenomas, extending the surveillance colonoscopy interval to ≥ 7 years did not significantly increase the detection of neoplastic polyps compared with earlier surveillance. Given the similar baseline characteristics and quality metrics between interval groups, these findings support the safety of the 2020 USMSTF recommendation for a 7-10 year surveillance interval. Larger studies may clarify whether delayed surveillance meaningfully affects advanced neoplasia risk.
Indexed as
Identifiers
42288690What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.